Quality control professionals in the pharmaceutical industry face a daunting landscape: evolving regulations, reliance on outdated microbial identification methods, and the pressing need for speed and cost efficiency, all while prioritizing patient safety.  

This comprehensive seminar offers an in-depth exploration of MALDI-TOF technology, showcasing its alignment with regulatory compliance, efficiency in workflow, and its comparative advantages over other sequencing methodologies.

Problems addressed: 

  • Misinterpretation of data: Discover how MALDI-TOF technology aids in accurate species and genus identification, avoiding costly and time-consuming errors 
  • Complexity in analysis: Simplify your microbial analysis by understanding how MALDI-TOF works and why it’s a more efficient alternative than traditional methods 
  • Operational and financial challenges: Purchasing and maintaining in-house MALDI-TOF equipment can be costly and complex compared to outsourcing MALDI-TOF services 

What you’ll learn: 

  • Essential role of MALDI-TOF in accurate ID: Grasp the critical importance of MALDI-TOF in identifying microorganisms accurately, ensuring product safety and compliance with regulatory standards 
  • Operational advantages of outsourcing MALDI services: Uncover why outsourcing MALDI-TOF services is more beneficial than investing in in-house capabilities, focusing on cost-effectiveness and specialized expertise 
  • Navigating MALDI-TOF limitations and data interpretation: Gain insights into interpreting MALDI-TOF results, understanding its limitations, and implementing best practices for accurate microbial identification 

Following the seminar, check out the Q&A with Duncan Barlow, Technology & Market Development Manager at Charles River and Stefan Karl, CEO at Mikrobiologisches Prüflabor to get answers to all of your MALDI-TOF Mass Spectrometry questions.  

This seminar is only available for a limited time. 

Seminar Presenters:

Duncan Barlow

Duncan Barlow
Technology & Market Development Manager

Duncan is a Technology & Market Development Manager for Charles River Microbial Solutions, specializing in Accugenix®. In this role, he supports customers with the implementation of microbial identification solutions across Europe and Asia. He has substantial experience with other QC microbial offerings such as endotoxin testing, rapid microbiological methods, and environmental monitoring.

Stefan Karl

Stefan Karl
CEO, Mikrobiologisches Prüflabor (MPL)

MPL is a GMP laboratory in Innsbruck, Austria, specializing in the field of contract analysis microbiology. Established as the first private GMP laboratory in Austria, the company specializes in the areas of testing sterile and non-sterile drugs and medical devices, as well as analytical services in the areas of clean room, hygiene, and isolator technology.

If you have any additional questions, give us a call at 1-800-886-9654 or email us at [email protected].